Focus Partners Wealth
TXG icon

Focus Partners Wealth’s 10x Genomics TXG Stock Holding History

Focus Partners Wealth’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.21M Sell
214,296
-10,200
-5% -$267K 0.01% 778
2026
Q1 		$4.83M Buy
224,496
+35,437
+19% +$708K 0.01% 944
2025
Q4 		$3.08M Buy
189,059
+145,536
+334% +$2.2M ﹤0.01% 1147
2025
Q3 		$589K Buy
43,523
+13,954
+47% +$182K ﹤0.01% 1548
2025
Q2 		$342K Buy
29,569
+18,991
+180% +$173K ﹤0.01% 1611
2025
Q1 		$92.3K Buy
+10,578
New +$133K ﹤0.01% 1818

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Focus Partners Wealth's TXG Position: Q2 2026 in Review

Focus Partners Wealth reduced its 10x Genomics (TXG) stake by 4.5% in Q2 2026, selling an estimated $267K and leaving 214,296 shares worth $8.21M. The position accounts for 0.01% of the portfolio, ranked #778.

Focus Partners Wealth first reported a position in TXG in Q1 2025 and has held it in 6 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Focus Partners Wealth held 214,296 shares of 10x Genomics worth $8.21M as of Q2 2026.
  • Focus Partners Wealth sold 10,200 10x Genomics shares in Q2 2026, an estimated $267K.
  • 10x Genomics made up 0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #778 holding.
  • Focus Partners Wealth first reported a position in 10x Genomics in Q1 2025 and has held it in 6 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.